Cardiovascular disease in patients with rheumatoid arthritis

Area of Science:

• Rheumatology
• Cardiology
• Immunology

Background:

• Rheumatoid arthritis (RA) significantly elevates cardiovascular disease (CVD) risk, with patients experiencing 1.5-2 fold higher rates compared to the general population.
• Systemic chronic inflammation, a key characteristic of RA, is the primary driver of this increased CVD risk.
• Understanding the interplay between RA and CVD is vital for developing effective prevention and management strategies.

Purpose of the Study:

• To highlight the elevated cardiovascular risk in rheumatoid arthritis patients.
• To identify challenges in optimizing cardiovascular risk management within the RA population.
• To explore how insights from RA research can inform broader cardiovascular disease prevention strategies.

Main Methods:

• Review of existing literature on rheumatoid arthritis and cardiovascular disease.
• Analysis of epidemiological data comparing CVD risk in RA patients versus the general population.
• Discussion of current challenges and future directions in managing cardiovascular risk in RA.

Main Results:

• Patients with RA exhibit a 1.5 to 2-fold higher risk of CVD compared to age- and sex-matched controls.
• Chronic systemic inflammation in RA is identified as the main contributor to this excess cardiovascular risk.
• Current cardiovascular risk management in RA faces hurdles in accurate risk prediction and identifying key modifiable risk factors.

Conclusions:

• The heightened CVD risk in RA underscores the critical role of inflammation in atherosclerosis.
• Improved methods for CV risk prediction and targeted interventions are needed for RA patients.
• Lessons from RA research offer valuable insights into the role of inflammation in cardiovascular health for the general population.